Obsidian Therapeutics, Inc. (OBX) News
Track canonical SquawkNews coverage tagged to OBX, Obsidian Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Obsidian Therapeutics initiated at Outperform by William Blair
William Blair initiated coverage of Obsidian Therapeutics with an Outperform rating, per Benzinga ratings actions.
EQUITY | Sep 09, 2026, 08:45 PM UTC
L
Obsidian Therapeutics files prospectus for resale of up to 29,164,045 shares
Obsidian Therapeutics filed a prospectus covering the resale of up to 29,164,045 shares of common stock by selling stockholders.
REGULATION | Aug 28, 2026, 09:16 PM UTC